Published in Pathophysiol Haemost Thromb on February 04, 2005
Simultaneous activation of complement and coagulation by MBL-associated serine protease 2. PLoS One (2007) 1.42
Concentration independent modulation of local micromechanics in a fibrin gel. PLoS One (2011) 1.11
Network screening of Goto-Kakizaki rat liver microarray data during diabetic progression. BMC Syst Biol (2011) 0.88
Factor XIIIA-V34L and factor XIIIB-H95R gene variants: effects on survival in myocardial infarction patients. Mol Med (2007) 0.79
Effect of Factor XIII-A G185T Polymorphism on Visual Prognosis after Photodynamic Therapy for Neovascular Macular Degeneration. Int J Mol Sci (2015) 0.78
Indwelling catheters and medical implants with FXIIIa inhibitors: A novel approach to the treatment of catheter and medical device-related infections. Eur J Pharm Biopharm (2012) 0.77
Blood pressure distribution in a Hungarian adolescent population: comparison with normal values in the USA. J Hypertens (2003) 1.44
Endothelial dysfunction and atherosclerosis in rheumatoid arthritis: a multiparametric analysis using imaging techniques and laboratory markers of inflammation and autoimmunity. J Rheumatol (2008) 1.29
Interaction of factor XIII subunits. Blood (2014) 1.12
New direct and indirect methods for the detection of cyclooxygenase 1 acetylation by aspirin; the lack of aspirin resistance among healthy individuals. Thromb Res (2013) 1.07
Factor XIII Deficiency. Semin Thromb Hemost (2009) 0.97
Factor XIII, clot structure, thrombosis. Thromb Res (2011) 0.95
Modulation of the risk of coronary sclerosis/myocardial infarction by the interaction between factor XIII subunit A Val34Leu polymorphism and fibrinogen concentration in the high risk Hungarian population. Thromb Res (2007) 0.93
Importance of ambulatory blood pressure monitoring in adolescent hypertension. Kidney Blood Press Res (2011) 0.93
Dietary self-efficacy: determinant of compliance behaviours and biochemical outcomes in haemodialysis patients. Nephrol Dial Transplant (2003) 0.91
Factor XIII Val34Leu variant protects against coronary artery disease. A meta-analysis. Thromb Haemost (2007) 0.90
Possible role of factor XIII subunit A in Fcgamma and complement receptor-mediated phagocytosis. Cell Immunol (2004) 0.90
Severe coagulation factor V deficiency caused by 2 novel frameshift mutations: 2952delT in exon 13 and 5493insG in exon 16 of factor 5 gene. Blood (2002) 0.85
Protein C and protein S deficiencies: similarities and differences between two brothers playing in the same game. Clin Chem Lab Med (2010) 0.85
Effects of menadione, hydrogen peroxide, and quercetin on apoptosis and delayed luminescence of human leukemia Jurkat T-cells. Cell Biochem Biophys (2010) 0.85
Assessment of target-organ damage in adolescent white-coat and sustained hypertensives. J Hypertens (2010) 0.84
Interaction between homocysteine and lipoprotein(a) increases the prevalence of coronary artery disease/myocardial infarction in women: a case-control study. Thromb Res (2011) 0.84
Severe bleeding complications caused by an autoantibody against the B subunit of plasma factor XIII: a novel form of acquired factor XIII deficiency. Blood (2008) 0.84
Phenotype-genotype characterization of 10 families with severe a subunit factor XIII deficiency. Hum Mutat (2004) 0.84
Three novel mutations in the glycoprotein IIb gene in a patient with type II Glanzmann thrombasthenia. Haematologica (2007) 0.84
Thrombomodulin-dependent effect of factor VLeiden mutation on factor XIII activation. Thromb Res (2011) 0.83
Factor XIII and inflammatory cells. Thromb Res (2012) 0.82
Factor XIII and atherothrombotic diseases. Semin Thromb Hemost (2010) 0.82
Elevated factor XIII level and the risk of peripheral artery disease. Haematologica (2008) 0.81
Platelets but not monocytes contribute to the plasma levels of factor XIII subunit A in patients undergoing autologous peripheral blood stem cell transplantation. Blood Coagul Fibrinolysis (2004) 0.81
Down-regulation of activated factor XIII by polymorphonuclear granulocyte proteases within fibrin clot. Thromb Haemost (2007) 0.81
Leukemic lymphoblasts, a novel expression site of coagulation factor XIII subunit A. Thromb Haemost (2006) 0.81
High-throughput scintillation proximity assay for transglutaminase activity measurement. Anal Biochem (2005) 0.80
Competitive enzyme-linked immonosorbent assay for N epsilon gamma-glutamyl lysine. Anal Biochem (2002) 0.80
Validation of reference genes for the determination of platelet transcript level in healthy individuals and in patients with the history of myocardial infarction. Int J Mol Sci (2013) 0.80
Factor XIII and venous thromboembolism. Semin Thromb Hemost (2011) 0.80
Hyperventilation-induced cerebrovascular reactivity among hypertensive and healthy adolescents. Kidney Blood Press Res (2006) 0.80
Elevated factor XIII level and the risk of myocardial infarction in women. Haematologica (2007) 0.80
Measurement of factor XIII activity in plasma. Clin Chem Lab Med (2012) 0.79
Binding of plasma factor XIII to thrombin-receptor activated human platelets. Thromb Haemost (2009) 0.79
Rapid detection of the factor XIII Val34Leu (163 G-->T) polymorphism by real-time PCR using fluorescence resonance energy transfer detection and melting curve analysis. Clin Chem Lab Med (2004) 0.79
Gender-related differences in adolescent hypertension and in target organ effects. J Womens Health (Larchmt) (2010) 0.79
Decreased factor XIII levels in factor XIII A subunit Leu34 homozygous patients with coronary artery disease. Thromb Res (2007) 0.79
GJB2 mutations in patients with non-syndromic hearing loss from Northeastern Hungary. Hum Mutat (2004) 0.79
Factor XIII subunits in human tears; their highly elevated levels following penetrating keratoplasty. Clin Chim Acta (2010) 0.79
[Frequency of hyperhomocysteinemia in hemodialysis patients with folic acid supplementation]. Orv Hetil (2002) 0.78
Thrombomodulin-dependent effect of factor V Leiden mutation on the cross-linking of α2-plasmin inhibitor to fibrin and its consequences on fibrinolysis. Thromb Res (2012) 0.78
[Epidemiological data of 15-18 year adolescents and the prevalence of hypertension in Debrecen. The Debrecen Hypertension Study]. Orv Hetil (2005) 0.78
Increased common carotid artery intima media thickness in adolescent hypertension: results from the Debrecen Hypertension study. Cerebrovasc Dis (2003) 0.77
A coagulation factor becomes useful in the study of acute leukemias: studies with blood coagulation factor XIII. Cytometry A (2008) 0.77
Special issue of the 10th EFCC Continuous Postgraduate Course in Clinical Chemistry: "New trends in classification, diagnosis and management of thrombophilia", October 2010, Dubrovnik, Croatia. Clin Chem Lab Med (2010) 0.77
Comparison of a new P2Y12 receptor specific platelet aggregation test with other laboratory methods in stroke patients on clopidogrel monotherapy. PLoS One (2013) 0.76
The impact of serum homocysteine on intima-media thickness in normotensive, white-coat and sustained hypertensive adolescents. Blood Press (2011) 0.76
The combined effect of fibrin formation and factor XIII A subunit Val34Leu polymorphism on the activation of factor XIII in whole plasma. Biochim Biophys Acta (2006) 0.76
Coagulation factor XIII-A. A flow cytometric intracellular marker in the classification of acute myeloid leukemias. Thromb Haemost (2005) 0.76
Angiotensin-converting enzyme gene polymorphism, carotid intima-media thickness, and left ventricular mass index in adolescent hypertension. J Clin Ultrasound (2004) 0.76
The superiority of anti-FXa assay over anti-FIIa assay in detecting heparin-binding site antithrombin deficiency. Am J Clin Pathol (2013) 0.76
[Lipid profile in patients with systemic lupus erythematosus, with special focus on lipoprotein(a) in lupus nephritis]. Orv Hetil (2004) 0.76
[Complementary therapies--based on the principles of evidence-based medicine. Position statement of the Medical Sciences Section of the Hungarian Academy of Sciences]. Orv Hetil (2011) 0.76
Progressive chromogenic anti-factor Xa assay and its use in the classification of antithrombin deficiencies. Clin Chem Lab Med (2014) 0.75
[Increase of homocysteine in cardiovascular diseases in Hungary]. Orv Hetil (2006) 0.75
Epigallocatechin 3-O-gallate induces 67 kDa laminin receptor-mediated cell death accompanied by downregulation of ErbB proteins and altered lipid raft clustering in mammary and epidermoid carcinoma cells. J Nat Prod (2014) 0.75
Factor XDebrecen: Gly204Arg mutation in factor X causes the synthesis of a non-secretable protein and severe factor X deficiency. Haematologica (2008) 0.75
Expression of coagulation factor XIII subunit A in acute promyelocytic leukemia. Cytometry B Clin Cytom (2012) 0.75
[Importance of ambulatory blood pressure monitoring in adolescent hypertension]. Orv Hetil (2009) 0.75
Assessment of thrombotic risk factors predisposing to thromboembolic complications in prosthetic orthopedic surgery. J Orthop Sci (2009) 0.75
[Assessment of cerebrovascular reactivity using the breath-holding test in hypertensive and normotensive adolescents--preliminary results]. Orv Hetil (2003) 0.75
Monitoring platelet function by PFA-100 closure time measurements during thrombolytic therapy of patients with myocardial infarction. Thromb Res (2005) 0.75
OS 24-01 ASSESSMENT OF TARGET-ORGAN DAMAGE IN ADOLESCENT WHITE COAT AND SUSTAINED HYPERTENSION. J Hypertens (2016) 0.75
Inherited factor V deficiency associated with a novel heterozygous missense mutation (p.G493R) in a patient with excessive surgical bleeding. Thromb Haemost (2009) 0.75
A highly sensitive chemiluminescence immunoassay for the measurement of coagulation factor XIII subunits and their complex in tears. J Immunol Methods (2010) 0.75
Variant type Glanzmann thrombasthenia caused by homozygous p.724R>X mutation in beta3 integrin. Thromb Res (2010) 0.75
[Prevention of target organ damage with modern antihypertensive agents]. Orv Hetil (2006) 0.75
Carotid intima-media thickness and cerebrovascular reactivity in long-term type 1 diabetes mellitus. J Clin Ultrasound (2009) 0.75
Factor XIII A subunit Val34Leu polymorphism in patients suffering atherothrombotic ischemic stroke. Thromb Res (2010) 0.75
A novel homozygous mutation (1619delC) in GPIIb gene associated with Glanzmann thrombasthenia, the decay of GPIIb-mRNA and the synthesis of a truncated GPIIb unable to form complex with GPIIIa. Thromb Haemost (2005) 0.75
[Anticoagulation with hirudin for repeat cardiac surgery in a patient with heparin induced thrombocytopaenia]. Magy Seb (2008) 0.75
OS 24-01 ASSESSMENT OF TARGET-ORGAN DAMAGE IN ADOLESCENT WHITE COAT AND SUSTAINED HYPERTENSION. J Hypertens (2016) 0.75
Quercetin as a fluorescent probe for the ryanodine receptor activity in Jurkat cells. Pflugers Arch (2013) 0.75